Insider · CIK 0001222644
Robert P Ragusa
Files at TWST (Twist Bioscience Corp), GRAL (GRAIL, Inc.), ALMR (Alamar Biosciences, Inc.). First filing Oct 17, 2024, latest Apr 9, 2026.
Robert P Ragusa files SEC Form 4 as CEO and director at GRAL (GRAIL, Inc.), and also at TWST (Twist Bioscience Corp), ALMR (Alamar Biosciences, Inc.). Since Oct 17, 2024, Robert P Ragusa has reported 0 open-market buys worth $0 and 10 open-market sells worth $18M, the latest filed on Apr 9, 2026.
A track record needs three past buys with six months of prices behind them; Robert P Ragusa has 0, so none is measured yet.
The newest scored trade: sold $6.2M of GRAL on Apr 8, 2026, filed Apr 9, 2026, scored 70 (notable). In the last 12 months: 0 buys worth $0 and 5 sells worth $13M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
GRAL: GRAIL, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 70Notable | GRAIL, Inc. | $6.2M 123,502 shares | -19% | +137% from low-56% from high | |
| 56Moderate | GRAIL, Inc. | $409k 8,441 shares | -1% | +142% from low-55% from high | |
| 65Notable | GRAIL, Inc. | $1.9M 37,504 shares | -5% | +146% from low-55% from high | |
| 65Notable | GRAIL, Inc. | $3.8M 40,000 shares | -5% | +490% from low-9% from high | |
| 51Moderate | GRAIL, Inc. | $499k 7,239 shares | -1% | +484% from low0% from high | |
| 70Notable | GRAIL, Inc. | $3.2M 94,035 shares | -11% | +185% from low-35% from high | |
| 53Moderate | GRAIL, Inc. | $238k 7,625 shares | -1% | +143% from low-44% from high | |
| 53Moderate | GRAIL, Inc. | $238k 7,625 shares | -1% | +162% from low-40% from high | |
| 46Moderate | GRAIL, Inc. | $41k 994 shares | -0% | +205% from low-30% from high | |
| 55Moderate | GRALsell GRAIL, Inc. | $1.7M 123,454 shares | -17% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 5, 2026 | GRAL GRAIL, Inc. | 9,285 0.02% of outstanding | $481k | Mar 5, 2026 | $1.3M |
| Mar 2, 2026 | GRAL GRAIL, Inc. | 40,641 0.10% of outstanding | $2.2M | Mar 2, 2026 | $3.8M |
| Dec 3, 2025 | GRAL GRAIL, INC. | 40,000 0.10% of outstanding | $3.8M | Dec 3, 2025 | $499k |
| Oct 14, 2025 | GRAL GRAIL, Inc. | 8,275 0.02% of outstanding | $573k | Oct 15, 2025 | none |
| Apr 29, 2025 | GRAL GRAIL, Inc. | 96,207 0.27% of outstanding | $3.5M | May 1, 2025 | $279k |
| Mar 3, 2025 | GRAL GRAIL, Inc. | 9,102 0.03% of outstanding | $331k | Mar 5, 2025 | none |
| Oct 11, 2024 | GRAL GRAIL, Inc. | 135,454 0.41% of outstanding | $2.0M | Oct 14, 2024 | none |
Transactions
Every row this insider has filed, 20 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | ALMR Alamar Biosciences, Inc. | AGrant or award Common Stock | +5,686 | $0.00 | $0 | 5,686 | 40 d ago |
| Sep 1, 2026 | ALMR Alamar Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +25,599 | $0.00 | $0 | 25,599 | 40 d ago |
| Apr 8, 2026 | GRAL GRAIL, Inc. | SOpen-market sale Common Stock | -123,502 | $49.92 | $6.2M | 518,582 | Apr 9, 2026 |
| Mar 5, 2026 | GRAL GRAIL, Inc. | SOpen-market sale Common Stock | -980 | $53.01 | $52k | 649,545 | Mar 9, 2026 |
| Mar 9, 2026 | GRAL GRAIL, Inc. | SOpen-market sale Common Stock | -7,203 | $47.93 | $345k | 642,342 | Mar 9, 2026 |
| Mar 9, 2026 | GRAL GRAIL, Inc. | SOpen-market sale Common Stock | -258 | $46.73 | $12k | 642,084 | Mar 9, 2026 |
| Mar 2, 2026 | GRAL GRAIL, Inc. | SOpen-market sale Common Stock | -35,787 | $50.09 | $1.8M | 652,242 | Mar 3, 2026 |
| Mar 2, 2026 | GRAL GRAIL, Inc. | SOpen-market sale Common Stock | -1,717 | $51.84 | $89k | 650,525 | Mar 3, 2026 |
| Feb 5, 2026 | TWST Twist Bioscience Corp | AGrant or award Common Stock | +5,095 | $0.00 | $0 | 28,983 | Feb 9, 2026 |
| Dec 3, 2025 | GRAL GRAIL, Inc. | SOpen-market sale Common Stock | -14,807 | $94.43 | $1.4M | 713,222 | Dec 5, 2025 |
| Dec 3, 2025 | GRAL GRAIL, Inc. | SOpen-market sale Common Stock | -15,356 | $95.28 | $1.5M | 697,866 | Dec 5, 2025 |
| Dec 3, 2025 | GRAL GRAIL, Inc. | SOpen-market sale Common Stock | -8,233 | $96.22 | $792k | 689,633 | Dec 5, 2025 |
| Dec 3, 2025 | GRAL GRAIL, Inc. | SOpen-market sale Common Stock | -1,604 | $97.28 | $156k | 688,029 | Dec 5, 2025 |
| Oct 15, 2025 | GRAL GRAIL, Inc. | SOpen-market sale Common Stock | -7,239 | $68.88 | $499k | 727,388 | Oct 16, 2025 |
| May 2, 2025 | GRAL GRAIL, Inc. | SOpen-market sale Common Stock | -94,035 | $33.93 | $3.2M | 734,627 | May 5, 2025 |
| Mar 11, 2025 | GRAL GRAIL, Inc. | SOpen-market sale Common Stock | -7,625 | $31.21 | $238k | 828,662 | Apr 3, 2025 |
| Mar 7, 2025 | GRAL GRAIL, Inc. | SOpen-market sale Common Stock | -7,625 | $31.21 | $238k | 828,662 | Mar 12, 2025 |
| Mar 5, 2025 | GRAL GRAIL, Inc. | SOpen-market sale Common Stock | -994 | $41.51 | $41k | 836,287 | Mar 6, 2025 |
| Feb 3, 2025 | GRAL GRAIL, Inc. | AGrant or award Common Stock | +224,620 | $28.84 | $6.5M | 837,281 | Feb 4, 2025 |
| Oct 15, 2024 | GRAL GRAIL, Inc. | SOpen-market sale Common Stock | -123,454 | $14.02 | $1.7M | 612,661 | Oct 17, 2024 |
Questions about Robert P Ragusa
Answered from the filings on this page, as of the latest one.
Is Robert P Ragusa buying or selling?
In the last 12 months Robert P Ragusa reported 0 open-market buys worth $0 and 5 open-market sells worth $13M on SEC Form 4; the latest was sold $6.2M of GRAL on Apr 8, 2026. Grants, option exercises and tax withholding are not counted.
How did Robert P Ragusa's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert P Ragusa has 0.
Where does Robert P Ragusa file Form 4?
Robert P Ragusa has filed Form 4 at GRAL (GRAIL, Inc.) as Chief Executive Officer; TWST (Twist Bioscience Corp); ALMR (Alamar Biosciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.